DSHEA Reform
Why it must be a priorityWhy DSHEA Reform Must Be a Priority
The recent wave of moringa-related contamination recalls – touching national retail chains and rippling through dozens of contract manufacturers – has forced an uncomfortable question into public view: How was a single tainted ingredient able to move so far through the marketplace before anyone intervened?
The trail leads directly to a statute passed more than three decades ago, a law once championed as a victory for “consumer choice” but which, in practice, dismantled critical safeguards. That law is the Dietary Supplement Health and Education Act of 1994 (DSHEA).
DSHEA created the regulatory framework that governs today’s $50-plus billion supplement industry – a marketplace that has expanded dramatically while federal oversight has remained largely static.
Under this system, manufacturers can introduce products with limited pre-market scrutiny, supply chains remain opaque, and the FDA is routinely constrained from acting until after harm has occurred. The current moringa situation is not an aberration; it is a predictable outcome of the regulatory gaps DSHEA institutionalized.
It is time to acknowledge an uncomfortable truth: DSHEA’s structure has failed consumers, and we are now paying the price.
DSHEA Is Seriously Outdated
The supplement industry of 1994 is not the industry of today. Back then, supplements were vitamins, minerals, and herbal capsules. Today, the industry includes:
-
- imported botanical powders from dozens of countries
-
- complex blends with dozens of ingredients
-
- bodybuilding products spiked with steroids
-
- stimulants chemically similar to banned drugs
-
- mushroom extracts with contamination risks
-
- superfood “greens” powders consumed daily, and
-
- private-label supplements made by unknown contract manufacturers
The risks are higher, the supply chains are longer, the testing is inconsistent, and the incentives to cut corners are greater. Yet the rules governing the industry are frozen in 1994.
Available in paperback and eBook formats on Amazon.
Click on the image or this link to see the book on the Amazon website.
How Reform Could Look
A reform that establishes true consumer protection would require the following.
Mandatory premarket product registration with FDA. The FDA still does not have a complete list of what supplements exist in the marketplace.
Batch-level contaminant testing requirements. Especially for imported botanicals like moringa, turmeric, mushroom powders, ashwagandha, etc.
Full supply chain transparency. Manufacturers should know their ingredient sources. And consumers should have access to that information.
Faster FDA authority to remove dangerous products. The burden should not require waiting for illness.
Clear labeling rules about potency and purity. Including known risks (e.g., heavy metals, stimulants).
Enforcement against misleading claims. Especially quasi-medical marketing that misleads consumers about efficacy or safety.
These reforms would not destroy the industry. They would protect legitimate manufacturers and shield consumers from preventable harm.
A Call for Consumer-Centered Supplement Reform
For three decades, DSHEA has been defended as a law about “freedom.” But freedom without accountability is how we get today’s system: Contaminated ingredients, incomplete recalls, hidden supply chains, mislabeled products, unsafe daily-use powders, and consumers who believe supplements are regulated when they are not.
The supplement marketplace should not be a gamble. Reform is not about restricting access – it is about ensuring safety, transparency, and accountability in a market where the risks have evolved far beyond what Congress imagined in 1994.
It is time to modernize DSHEA. Consumers deserve a regulatory system that protects their health, not one that hopes someone gets sick before a problem is caught.
Why DSHEA No Longer Works – A Point-by-Point Critique
No Pre-Market Review of Safety or Quality
DSHEA allows supplements to enter the market without FDA evaluation of safety, purity, or manufacturing controls. Unlike drugs or even food additives, supplements face no systematic verification before consumers are exposed to them.
Manufacturers Are Largely Self-Policing
Under DSHEA, companies are responsible for determining whether their products are safe. This “honor-system” model fails when supply chains span multiple countries, contract manufacturers, and bulk ingredient brokers – a structure ripe for contamination and adulteration.
Opaque and Fragmented Supply Chains
DSHEA does not require manufacturers to disclose ingredient origins, testing protocols, or downstream distributors. As a result, a single contaminated ingredient can quietly infiltrate dozens of brands, with no mandatory traceability until people get sick.
FDA Cannot Act Until Harm Occurs
The agency’s authority is overwhelmingly reactive. Unless there is clear evidence of illness or injury, FDA has limited power to compel recalls, demand records, or stop distribution – leaving consumers unprotected until after an outbreak has already taken root.
“Structure/Function Claims” Blur the Line with Medicine
DSHEA permits companies to make quasi-therapeutic claims (“supports immunity,” “promotes hormonal balance,” etc.) without scientific validation. These claims mislead consumers while evading drug-level standards, turning the supplement aisle into a pseudo-medical marketplace.
Minimal Requirements for Adverse-Event Reporting
Serious adverse events must be reported, but non-serious events are not, creating a distorted safety profile. Even required reports often lack clinical detail, making trends invisible until they escalate.
Enforcement Resources Are Inadequate for a $50B Industry
The FDA office responsible for supplements oversees tens of thousands of products with a fraction of the staffing and budget allocated to food or drug oversight. DSHEA created a regulatory regime without providing the tools to enforce it.
New Dietary Ingredient (NDI) Rules Are Functionally Broken
DSHEA requires notification before introducing a “new dietary ingredient,” but the process is unclear, underused, and unenforced. Many companies simply sidestep the requirement, resulting in unknown, untested substances entering the marketplace.
Globalization Has Outpaced DSHEA’s Design
In 1994, supply chains were domestic and simpler. Today, they span India, China, Latin America, Eastern Europe, and hundreds of contract labs. DSHEA was never built to regulate a modern, globalized industry – and it shows.
Consumer Perception of “Safety by Default” Is False
DSHEA’s framework – and decades of marketing – have conditioned consumers to assume supplements are vetted like foods or drugs. They are the least regulated products sold for ingestible health purposes in the United States.